Tilray Brands, Inc. reported $963M of revenue over the trailing twelve months, +16% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $963M (to Q1 2027). Net income: −$164M, trailing twelve months to Q1 2027. Operating margin: −9.6%, trailing twelve months to Q1 2027. EPS: −$1.41, trailing twelve months to Q1 2027.

TLRYTilray Brands, Inc.

Healthcare

$3.60-79% 1Y

$3.60

$3.5752 weeks$21.00

TLRY as reported

Tilray Brands, Inc. reported $963M of revenue over the trailing twelve months, +16% on the year before. 10 reported series are charted on this page, each one as filed.

$963M

Revenue, trailing twelve months · to Q1 2027 · +16% against the twelve months before

Net income: −$164M
Net income · −92% year on year · trailing twelve months to Q1 2027
Operating margin: −9.6%
Operating margin · trailing twelve months to Q1 2027
EPS: −$1.41
EPS · −94% year on year · trailing twelve months to Q1 2027

Details›

Every series Ryufin has for TLRY, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$963M	+16%	Q1 2027
Net income	−$164M	−92%	Q1 2027
EPS	−$1.41	−94%	Q1 2027
Gross margin	29%	n/a	Q1 2027
Operating margin	−9.6%	n/a	Q1 2027
Net margin	−17%	n/a	Q1 2027
ROE	−59%	n/a	Q1 2027
ROA	−44%	n/a	Q1 2027
ROIC	−58%	n/a	Q1 2027
Free cash flow	−$128M	n/a	Q4 2025 · 5 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.